In situ formed anti-inflammatory hydrogel loading plasmid DNA encoding VEGF for burn wound healing
Source abstract
Abstract
Excessive inflammation and reduced angiogenesis are two major obstacles in burn wound healing and skin regeneration. Here we report the fabrication and application of a sophisticated hydrogel from chemically modified hyaluronic acid (HA), dextran (Dex), and β-cyclodextrin (β-CD) integrating resveratrol (Res) and vascular endothelial growth factor (VEGF) plasmid as the anti-inflammatory and pro-angiogenic components for burn wounds. Firstly, covalent alterations were conducted to obtain methacrylic acid anhydride modified HA (HAMA), N-hydroxyethylacrylamide (HEAA) modified Dex (Dex-HEAA), and poly(ethylene glycol) methyl acrylate (526) modified β-CD (526-β-CD), respectively. Secondly, anti-inflammatory substance Res was embedded into the lipophilic central cavity of 526-β-CD to achieve a complex of 526-β-CD-Res. Then hydrogels with different HAMA, Dex-HEAA, and 526-β-CD-Res ratios were generated via UV irradiation. Lastly, plasmid DNA encoded with vascular endothelial growth factor (pDNA-VEGF) conjugating with polyethylenimine was loaded into the hydrogel scaffold. Combining the benefits of all components of the scaffold, the hydrogel embedded with Res and VEGF (Gel-Res/pDNA-VEGF) accelerated the splinted excisional burn wound healing, particularly by inhibiting inflammation response and promoting microvascular formation while being biocompatible. The Res and VEGF gene loaded hydrogel system can be considered as a promising wound dressing for the treatment of various types of wounds. STATEMENT OF SIGNIFICANCE: Combining the benefits of all components of the scaffold, the hydrogel embedded with Res and VEGF (Gel-Res/pDNA-VEGF) accelerated the splinted excisional burn wound healing, particularly by inhibiting inflammation response and promoting microvascular formation while being biocompatible. The Res and VEGF gene loaded hydrogel system can be considered as a promising wound dressing for the treatment of various types of wounds.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Wound Healing and Treatments · Electrospun Nanofibers in Biomedical Applications · Silk-based biomaterials and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (44)
Show source-provided references
1. Burn wound healing: present concepts, treatment strategies and future directions10.12968/jowc.2017.26.1.5 ↗
2. Wound repair and regeneration : mechanisms, signaling, and translation10.1126/scitranslmed.3009337 ↗
3. Wound repair and regeneration10.1038/nature07039 ↗
4. Reversal of capillary stasis and prevention of necrosis in burns10.1097/00000658-197407000-00015 ↗
5. Burn wound healing and skin substitutes10.1016/S0305-4179(01)00017-1 ↗
6. Ultraviolet-Radiation induced skin inflammation: dissecting the role of bioactive lipids10.1016/j.chemphyslip.2011.04.005 ↗
7. 2-Chloroethyl Ethyl sulfide causes microvesication and inflammation-related histopathological changes in male hairless mouse skin10.1016/j.tox.2011.01.021 ↗
8. The kinase P38α serves cell type-specific inflammatory functions in skin injury and coordinates pro- and Anti-Inflammatory gene expression10.1038/ni.1640 ↗
9. Targeting inflammation and wound healing by opioids10.1016/j.tips.2013.03.006 ↗
10. Novel therapies for scar reduction and regenerative healing of skin wounds10.1016/j.tibtech.2007.12.007 ↗
11. Regulation of wound healing by growth factors and cytokines10.1152/physrev.2003.83.3.835 ↗
12. Clinical application of growth factors and cytokines in wound healing10.1111/wrr.12205 ↗
13. Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells10.1016/S0002-9440(10)63754-6 ↗
14. Growth factors and cytokines in wound healing10.1111/j.1524-475X.2008.00410.x ↗
15. Protection against severe intestinal ischemia / reperfusion injury in rats by intravenous resveratrol10.1016/j.jss.2010.06.004 ↗
16. Effects of resveratrol on incisional wound healing in rats10.1007/s00595-012-0455-7 ↗
17. Biomaterials the effect of resveratrol on neurodegeneration and blood brain barrier stability surrounding intracortical microelectrodes10.1016/j.biomaterials.2013.05.035 ↗
18. Therapeutic potential of resveratrol: the in vivo evidence10.1038/nrd2060 ↗
19. An anti-inflammatory cell-free collagen/resveratrol scaffold for repairing osteochondral defects in rabbits10.1016/j.actbio.2014.08.022 ↗
20. D. Wound, H. Properties, O.F.R. Grape, S. Proanthocyanidins, Dermal wound healing properties of redox-active grape. 33(8) (2002), 1089–1096.10.1016/S0891-5849(02)00999-1 ↗
21. Coordinated induction of INOS-VEGF-KDR-ENOS after resveratrol consumption a potential mechanism for resveratrol preconditioning of the heart10.1016/j.vph.2005.02.013 ↗
22. Resveratrol promotes endothelial cell wound healing under laminar shear stress through an estrogen receptor-α-dependent pathway10.1152/ajpheart.00892.2013 ↗
23. Resveratrol engages AMPK to attenuate ERK and MTOR signaling in sensory neurons and inhibits incision-induced acute and chronic pain10.1186/1744-8069-8-5 ↗
24. Resveratrol-Containing gel for the treatment of acne vulgaris: a single-blind, vehicle-controlled, pilot study10.2165/11530630-000000000-00000 ↗
25. Enhanced antioxidant effect of trans-resveratrol: potential of binary systems with polyethylene glycol and cyclodextrin10.3109/03639045.2013.817416 ↗
26. Dermal wound healing properties of redox-active grape seed proanthocyanidins10.1016/S0891-5849(02)00999-1 ↗
27. Resveratrol-Conjugated poly-ε-caprolactone facilitates in vitro mineralization and in vivo bone regeneration10.1016/j.actbio.2010.09.008 ↗
28. Recent advances on the development of wound dressings for diabetic foot ulcer treatment – a review10.1016/j.actbio.2013.03.033 ↗
29. 25th Anniversary article: rational design and applications of hydrogels in regenerative medicine10.1002/adma.201303233 ↗
30. Hyaluronic acid hydrogels for biomedical applications10.1002/adma.201003963 ↗
31. Dextran hydrogel scaffolds enhance angiogenic responses and promote complete skin regeneration during burn wound healing10.1073/pnas.1115973108 ↗
32. Biomaterials functional neovascularization of biodegradable dextran hydrogels with multiple angiogenic growth factors10.1016/j.biomaterials.2010.08.091 ↗
33. E. Pinho, M. Grootveld, M. Henriques, Cyclodextrin-Based hydrogels toward improved wound dressings. 2013, 8551, 1–10.
34. Drug delivery by supramolecular design10.1039/C7CS00391A ↗
35. Complexation of resveratrol with cyclodextrins: solubility and antioxidant activity10.1016/j.foodchem.2008.04.042 ↗
36. Design and development of polymers for gene delivery10.1038/nrd1775 ↗
37. Differential effect of hypoxia on human mesenchymal stem cell chondrogenesis and hypertrophy in hyaluronic acid hydrogels10.1016/j.actbio.2013.12.015 ↗
38. Preparation and characterization of nanoparticles based on dextran-drug conjugates10.1016/j.jcis.2009.05.025 ↗
39. Analysis of relative gene expression data using real-time quantitative pcr and the 2-ΔΔCT method10.1006/meth.2001.1262 ↗
40. Surgical approaches to create murine models of human wound healing
41. Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds10.1046/j.1523-1747.1998.00381.x ↗
42. The biology of burn injury10.1111/j.1600-0625.2010.01105.x ↗
43. Evaluation of dermal tissue regeneration using resveratrol loaded fibrous matrix in a preclinical mouse model of full-thickness ischemic wound10.1016/j.ijpharm.2019.01.001 ↗
44. The role of Hyaluronan in wound healing10.1111/j.1742-481X.2012.01057.x ↗